News
Anorexia and diarrhea top list of GI symptoms in COVID-19 patients
December 30, 2020
Increased ALT levels were the most common sign of abnormal liver function in adults with severe COVID-19.
News
COVID-19 vaccines: Safe for immunocompromised patients?
December 17, 2020
Data are limited thus far, and the safety and efficacy of the COVID-19 vaccines in immunocompromised patients remain unknown.
News
C. difficile control could require integrated approach
December 9, 2020
Australian researchers call for a One Health approach to limit spread.
News
Upper GI bleeds in COVID-19 not related to increased mortality
December 9, 2020
A Spanish survey suggests upper GI bleeding and delays in endoscopies in COVID-19 patients have little effect on in-hospital mortality.
News
Mortality higher in older adults hospitalized for IBD
December 4, 2020
Adults older than 65 years had significantly higher rates of inpatient IBD mortality than those under 65 years.
News
Rationale for baricitinib’s use in COVID-19 patients demonstrated
November 24, 2020
“We went from modeling and mechanistic investigations to clinical tests in a number of settings and laboratory analysis in record time,” Dr. Justin Stebbing said.
News
Liver injury linked to COVID-19–related coagulopathy
November 18, 2020
Cells that line the liver’s blood vessels produce high levels of factor VIII, a coagulation factor, when they are exposed to interleukin-6, an inflammatory molecule associated with COVID-19.
News
New eGFR equation ‘less biased’ by age, kidney function; some disagree
November 10, 2020
The European Kidney Function Consortium equation surpasses existing equations by "resulting in generally lower bias across the spectrum of age and kidney function," according to its developers.
News
FIT unfit for inpatient, emergency settings
November 5, 2020
The inappropriate use of FIT in these settings had no positive effect on clinical decision-making.
News
Antibiotics fail to improve colon ischemia outcomes
November 3, 2020
There were no differences in 30-day mortality between groups that received antibiotics and those that did not.